{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:25Z","timestamp":1780750765850,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":11,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_20","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:59:20Z","timestamp":1753707560000},"page":"305-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice Modulation"],"prefix":"10.1007","author":[{"given":"Ngoc","family":"Lu-Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"3","key":"20_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig M, Hoffman EP, Bertelson CJ et al (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50(3):509\u2013517","journal-title":"Cell"},{"issue":"4","key":"20_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","volume":"54","author":"E Bonilla","year":"1988","unstructured":"Bonilla E, Samitt CE, Miranda AF et al (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54(4):447\u2013452","journal-title":"Cell"},{"issue":"6914","key":"20_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TO, Barton ER et al (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420(6914):418\u2013421","journal-title":"Nature"},{"issue":"7","key":"20_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1517\/14712590903029164","volume":"9","author":"C Trollet","year":"2009","unstructured":"Trollet C, Athanasopoulos T, Popplewell L et al (2009) Gene therapy for muscular dystrophy: current progress and future prospects. Expert Opin Biol Ther 9(7):849\u2013866","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"20_CR5","doi-asserted-by":"publisher","first-page":"276S","DOI":"10.1042\/bst024276s","volume":"24","author":"MG Dunckley","year":"1996","unstructured":"Dunckley MG, Eperon IC, Dickson G (1996) Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene. Biochem Soc Trans 24(2):276S","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"20_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/mt.2010.261","volume":"19","author":"A Malerba","year":"2011","unstructured":"Malerba A, Sharp PS, Graham IR et al (2011) Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice. Mol Ther 19(2):345\u2013354","journal-title":"Mol Ther"},{"issue":"1","key":"20_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/mt.2010.212","volume":"19","author":"JK Kang","year":"2011","unstructured":"Kang JK, Malerba A, Popplewell L et al (2011) Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa-guanidine morpholino oligomer treatment. Mol Ther 19(1):159\u2013164","journal-title":"Mol Ther"},{"issue":"12","key":"20_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.54","volume":"1","author":"A Malerba","year":"2012","unstructured":"Malerba A, Kang JK, McClorey G et al (2012) Dual myostatin and dystrophin exon skipping by morpholino nucleic acid oligomers conjugated to a cell-penetrating peptide is a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy. Mol Ther Nucleic Acids 1(12):e62","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"20_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/mt.2015.88","volume":"23","author":"NB Lu-Nguyen","year":"2015","unstructured":"Lu-Nguyen NB, Jarmin SA, Saleh AF et al (2015) Combination antisense treatment for destructive exon skipping of myostatin and open reading frame rescue of dystrophin in neonatal mdx mice. Mol Ther 23(8):1341\u20131348","journal-title":"Mol Ther"},{"issue":"6","key":"20_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtn.2016.11.009","volume":"3","author":"N Lu-Nguyen","year":"2017","unstructured":"Lu-Nguyen N, Malerba A, Popplewell L et al (2017) Systemic antisense therapeutics for dystrophin and myostatin exon splice modulation improve muscle pathology of adult mdx mice. Mol Ther Nucleic Acids 3(6):15\u201328","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"20_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13395-018-0171-0","volume":"8","author":"A Mayeuf-Louchart","year":"2018","unstructured":"Mayeuf-Louchart A, Hardy D, Thorel Q et al (2018) MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool. Skelet Muscl 8(1):25","journal-title":"Skelet Muscl"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:07:13Z","timestamp":1780747633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}